S U M M A R Y The responses of baboon cerebral and extracerebral arteries to prostaglandin endoperoxide (PGH2) and prostacyclin (PGI2) were investigated on isolated arteries and in vivo by serial angiography. Both PGH2 and PGI2 could produce dose-dependent contraction or relaxation of isolated arteries. PGH2 induced relaxation was indicative of prostacyclin synthetase activity, the enzyme which converts PGH2 to PGI2. In isolated arteries tested one to four hours post mortem only the vertebral artery showed prostacyclin synthetase activity. Thus PGH2 induced contraction of cerebral arteries may be indicative of a physiological function. Vasomotor tone may in part be the result of a balance between PGH2 constriction and PGI2 dilatation. In vivo PGI2 infusion caused pronounced and prolonged dilatation of cerebral arteries, which lasted longer than the cardiovascular changes. As PGI2 is the most potent cerebral vasodilator drug tested, it may be of clinical use in the treatment of cerebral vasospasm.
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Prostacyclin is a recently discovered prostaglandin with potent vasodilator effects on peripheral and central blood vessels. In addition prostacyclin is one of the most potent inhibitors of platelet aggregation known. The potential therapeutic applications of the use of this drug or more stable analogues is currently under study (Moncada and Vane, 1978) .
In view of its potent relaxing actions on human and baboon cerebral arteries (Boullin et al., 1979) prostacyclin may be of use in the prevention or reversal of cerebral arterial vasospasm which commonly occurs after the rupture of aneurysms of the major cerebral arteries.
Before any clinical studies it is of course necessary to examine the actions of prostacyclin and precursors (prostaglandin endoperoxides, PGG2, PGH2) upon the cerebral vasculature of animals.
For some years we have been using the baboon as a model for studying the aetiology of human vasospasm (see Boullin et al., 1977 .
Accordingly it was relevant to test the effects of prostacyclin and PGH2 on this system.
In this paper we describe their effects on baboon arteries in vitro and in vivo after systemic administration and visualisation by carotid angiography.
In addition to confirming the previous reports of the vasodilator effects of prostacyclin itself, we now find that both PGH2 and prostacyclin can produce constrictor actions in appropriate dosage.
Methods

ISOLATED ARTERIES
Male baboons, body weight 6-14 kg, were killed by intravenous injection of pentobarbitone sodium (140 mg/kg). The basilar, vertebral, middle cerebral (MCA), anterior cerebral (Ant CA), abdominal aorta, femoral, and superior mesenteric arteries were removed within one hour of death and placed in Krebs solution (Starling et al., 1975) at 40C. Thereafter the tissues were refrigerated for up to four days post mortem. To test the effects of drugs the arteries were dissected spirally and mounted in a 10 ml isolated organ bath. Further 677 details are given in previous papers (Starling et al., 1975; Boullin et al., 1976 Boullin et al., , 1977 . Isotonic contractions of the muscles were amplified by transducer and recorded as previously described.
RESPONSES OF BABOON ARTERIES IN VIVO
The method for studying drug actions on the calibre of baboon cerebral arteries in vivo is described in detail by . Animals were anaesthetised with halothane and the major cerebral arteries visualised by sequential carotid angiography using 60% Urografin 290 (sodium and meglumine diatrizoate). Angiography was performed before and after drug administration. (Moncada et al., 1976 (Moncada et al., 1976; Needleman et al., 1977) . We have also observed variable effects on baboon cerebral arteries here. Because PGH2 relaxations are believed to be due to conversion of PGH2 to PGI2 by the enzyme prostacyclin synthetase, we studied the actions of PGH, at varying times post mortem; we expected PGH2 relaxations to be seen only shortly after death. In fact relaxations were only seen with the verebral artery. All other cerebral arteries produced contractions to PGH2 even when tested one to four hours post mortem as described below.
With regard to PGH2 induced relaxations on the vertebral artery, we made five tests within 48 hours of death and PGH2 caused relaxation each time. Tests made on day 3 produced contraction.
On successive days post mortem typical results are shown in Fig. 1 . On day 1, 14-16 hours post mortem the responses to two doses of PGH2 were triphasic: an initial very rapid contraction, then relaxation which gradually was reversed and followed by sustained contraction (Fig. 1, day 1 , left record).
At this time cumulative doses of PGI2 produced the typical responses of relaxation with low doses. As will be described below, high concentrations of PGI2 caused contraction (Fig. 1 , day 1, right record). On day 2 when the protocols with PGH2 and PGI2 were repeated early in the day (38-40 hours post mortem, Fig. 3 , record A) the responses to both PGH2 and PGI2 were qualitatively similar to those on day 1 but quantitatively greater. Our experience with both human and baboon cerebral arteries is that their responses to drugs are maximal on the second day.
One hour later on day 2 (Fig. 1, record B) , however, PGH2 no longer caused relaxation but merely a two phase contraction. At this time PGI2 responses on the other hand were not altered (records not shown). The pattern of responses of day 2 was repeated on day 3; again PGH2 produced only contraction. Of the peripheral arteries only the femoral artery produced a triphasic response to PGH2 similar to that shown in Fig. 1 .
We conclude from the data shown in Fig. 1 that the contractile effects of PGH2 are a direct action on the arterial muscle, while secondary relaxation is mediated by conversion of PGH2 to PGI2 by prostacyclin synthetase present in the walls of the arterial vessels (See Discussion). Therefore it was surprising to find that all other arteries only contracted to PGH2 even when tested within four hours of death. PGH2 caused dose-dependent contractions of all cerebral arteries in concentrations from 0.3 to 100 nmol/l with no evidence of responses reaching a maximum (Fig. 2) It must be emphasised that on vertebral arteries also, PGH2 produced dose-dependent contractions and that threshold doses caused contraction and not relaxation (Fig. 3) ; it was not the other way round. Concentrations of PGH, above 10 nmol/l produced triphasic responses: an initial transient contraction which was rapidly followed by a relaxation. The last phase of response was a contraction; the second and third phases were dose-dependent.
Arterial calibre in situ PGH2 was tested in only one experiment because of shortage of material. Doses of 4 and 10 ,ug were injected intra-arterially and angiograms performed 4-5 min thereafter. There was no significant change in the calibre of the cerebral vessels examined.
EFFECTS OF PROSTACYCLIN (PG1.)
Isolated arteries Isolated arteries responded to PGI., in two ways: low concentrations between 0.3 to 800 nmol/l caused dose-dependent relaxations; very high concentrations (over 0.8 jImol/l), probably outside the physiological range (see Discussion), produced dose-dependent contractions. Both types of response are shown in Fig. 1 ; dose-response curves for PGI, on various cerebral and extracerebral arteries are shown in Fig. 4a and b . 
Prostacyclin (PGJ2) in vivo
The actions of PGI2 on the blood pressure, heart rate, and calibre of cerebral blood vessels were studied in four baboons by sequential angiography 10 min to three hours after administration.
Five experiments were made as one animal was used twice with an interval of two months between experiments. In four experiments PGI2 was administered systematically and once intracranially into the subarachnoid space using the procedure described by .
PGI2 was given by intra-arterial infusion in two experiments over 2-10 min in doses of 68 ng/kg and 29 ,ug/kg (180 pmol/kg and 77 nmol/kg). These doses produced profound changes in the cardiovascular system (severe hypotension and bradycardia) lasting 20-40 min but there was no change in the calibre of the major cerebral arteries.
We also gave PGI2 by intravenous infusion (femoral vein) in another two experiments. The doses were 4.5 and 13 ,ug/kg in one experiment and 83 ,tg/kg in another (12, 35, and 221 nmol/kg). The results of an experiment involving intravenous administration are given in Fig. 5 . The upper record shows that there was pronounced dilatation of the major intracranial vessels (internal carotid; middle and anterior cerebral arteries). In contrast, the only extracranial artery measured (internal maxillary) showed profound vasoconstriction. This probably occurred as a consequence of the cardiovascular changes observed. These are illustrated in the lower record of Fig. 5 . The first dose of PGI2 which caused the most substantial changes in cerebral arterial calibre caused a moderate fall in pulse pressure and bradycardia; the second dose of PGI2 which caused little further cerebral arterial dilatation, did produce severe hypotension and compensatory tachycardia, lasting 10 minutes. Thus arterial dilatation after intravenous PGI2 occurred in the absence of severe changes in blood pressure or heart rate. The effects of PGI2 given intracisternally were also studied in one baboon; PGI2 was given through a needle inserted into the cisterna magna. PGI2 31 ,ug/kg was administered by a slow infusion (0.6 ml/1.5 min). The effects on cerebral arterial calibre and the cardiovascular system are shown in Fig. 6 (upper and lower records respectively).
Immediately before PGI2 infusion the cerebral arteries showed some change in calibre in comparison with the baseline angiogram (time 0, upper records). A second angiogram 10 min after infusion showed dilatation of all cerebral vessels, but this dilatation was not sustained. Thereafter substantial constriction developed in all intracranial vessels. These were a pronounced and prolonged bradycardia with slowly developing hypotension (Fig. 6 lower records) . 100 
COMPARISON WITH OTHER DRUGS
We have previously reported the effects of dopamine and 5-HT on human and baboon isolated cerebral arteries (Boullin et al., 1977 ) and these will not be described in detail here.
Dopamine causes dose-dependent relaxation in low concentrations and contraction in high concentrations, while 5-HT produces only dosedependent contractions. Table 2 gives a comparison of the effects of PGH., and PGI.L with dopamine (DM), 5-hydroxytryptamine (5-HT) , and noradrenaline (NA). PGI, was 15 to 30 times more potent than DM in relaxing or contracting the anterior cerebral and vertebral arteries. On the other hand NA was much more potent than PGI2 in its contractile effects (eight to four times from Table 2 ). Finally Table 2 shows that PGH2 and 5-HT were of approximately equal potency as vasoconstrictors.
Discussion
Although PGH2 has been shown by other workers to contract peripheral arteries in vitro including rabbit aorta, pig coronary artery, and human umbilical artery (Hamberg et al., 1975; Ellis et al., 1976; Tuvemo et al., 1976) , there did not appear to be any previous reports other than our own of PGH, contracting cerebral arteries in vitro (Boullin et al., 1979) . Although our previous Fig. 6 Effect ofintracisternal PGl2 on cerebral arterial calibre (upper records) and bloodpressure and heart rate (lower records). At the arrow PGI2 31 pg/kg was infused through a needle inserted into the cisterna magna. Infusion of0.6 ml was made in 90 seconds. The results ofupper and lower records were obtained in a single animal. Data were recorded as described in Fig. 5 except that the systolic/diastolic bloodpressure is indicated by bars attached to solid circles (0). The following symbols are used to identify various portions ofintracranial and extracranial arteries: MCi, main trunk ofmiddle cerebral; C2, intracranial carotid; ACi, main trunk ofanterior cerebral; C3, termination ofintracranial internal carotid; MC2, branch ofMCi; MC3, branch ofa branch ofMC, (ie branch ofMC2); Ci, extracranial internal carotid; IM, internal maxillary. (1979) found that the enzyme was also viable in the 'human basilar artery at this time, and in a variety of baboon arteries half to three hours after death.
However, the percentage conversion of PGH2 to PGI2 was low in all arteries except the vertebral and middle cerebral arteries. The failure to find sufficient conversion of PGH2 to PGI2 to relax any baboon cerebral artery except the vertebral in the current work, reinforces the view that prostaglandin endoperoxides may exert direct effects on cerebral vessels. An alternative possibility is that, in the absence of prostacyclin synthetase, prostaglandin endoperoxides are transformed rapidly to PGE2 which is a potent constrictor of human and baboon cerebral arteries (Boullin et al., 1976 (Boullin et al., , 1977 . It is not possible to determine the significance of prostacyclin synthetase in relation to responses of cerebral arteries without an extended study in different species.
The relaxing actions of PGI2 on isolated arteries have been described earlier by for human abdominal vessels and by Boullin et al. (1979) for human and baboon cerebral vessels. In addition to confirming these results, we now show that intravenous PGI2 is a potent cerebral vasodilator. Doses in the nmol/kg range produced dramatic and prolonged dilatation of all cerebral arteries measurable on angiograms. The effects were extremely prolonged (more than one and a quarter hours, Fig. 5 ) and occurred in the absence of severe changes in blood pressure and heart rate. These vasodilator actions were greater than in other experiments when there was severe hypotension and compensatory tachycardia. It is possible that the rather surprising failure of intra-arterial prostacyclin to cause cerebral arterial dilatation was the result of the systemic hypotension. Du Boulay et al. (1972 , 1973 showed that systemic hypotension resulted in as much as 20% constriction of the major cerebral arteries. The dilatation seen here in the face of hypotension, therefore, was remarkable in view of the vasoconstriction which could be predicted.
Intracisternal prostacyclin also caused transient vasodilatation but this was followed by constriction. The haemodynamic changes were different from those seen with systemic prostacyclin, in that hypotension was not accompanied by tachycardia, but rather bradycardia. These effects (Boullin et al., 1977) , there is the possibility that prostacyclin or more stable analogues may be of value in the treatment of spasm.
The constrictor effects of high concentrations of PGI2 seem unlikely to have any physiological significance because the rates of PGI2 synthesis by arteries and the heart are in the ng/g/min (pmol/g/min) range (De Deckere et al., 1977; Boullin et al., 1979) . There was no vasoconstrictor effect of PGL2 in situ, which probably reflects the rapid rate of hydrolysis of PGI2 to 6-oxo-PGFIa .
As regards the cause of vasospasm after subarachnoid haemorrhage, there is now evidence for the presence of unidentified vasoconstrictor factors in CSF of subarachnoid haemorrhage which are related to the severity of spasm and mortality (Blaso, 1978; Blaso and Boullin, 1978;  Boullin and Blaso, 1978) . Moreover in these same patients who died with angiographic evidence of vasospasm, Schianchi and Hughes (1978) have reported pathological changes in the endothelium of cerebral arteries known to have been in spasm during life (confirmed in experimental animal models by Tanake et al., 1978) . As the endothelium is the site of prostacyclin synthetase, there is reason to implicate PGI2 in the aetiology of vasospasm after subarachnoid haemorrhage. Consequently vasospasm might involve defective prostacyclin synthetase leading to PGI2 deficiency, allowing prostaglandin endoperoxide (PGH2) constrictor actions to become dominant. These defects in prostaglandin actions would be additional to the actions of the unidentified vasoconstrictor factors in CSF. 
